-
Je něco špatně v tomto záznamu ?
Antioxidants change platelet responses to various stimulating events
A Sobotkova, L Masova-Chrastinova, J Suttnar, J Stikarova, P Majek, Z Reicheltova, R Kotlin, JW Weisel, M Maly, JE Dyr
Jazyk angličtina Země Spojené státy americké
Typ dokumentu Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
NS10633
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- agregace trombocytů fyziologie účinky léků MeSH
- antioxidancia farmakologie MeSH
- buněčná adheze fyziologie účinky léků MeSH
- chromany (dihydrobenzopyrany) farmakologie MeSH
- cyklooxygenasa 1 metabolismus MeSH
- hemostáza účinky léků MeSH
- kolagen MeSH
- kultivované buňky MeSH
- lidé MeSH
- malondialdehyd metabolismus MeSH
- stilbeny farmakologie MeSH
- thromboxan B2 metabolismus MeSH
- trombocyty fyziologie účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
The role of platelets in hemostasis may be influenced by alteration of the platelet redox state-the presence of antioxidants and the formation of reactive oxygen and nitrogen species. We investigated the effects of two antioxidants, resveratrol and trolox, on platelet activation. Trolox and resveratrol inhibited aggregation of washed platelets and platelet-rich plasma activated by ADP, collagen, and thrombin receptor-activating peptide. Resveratrol was a more effective agent in reducing platelet static and dynamic adhesion in comparison with trolox. The antioxidant capacity of resveratrol was, however, the same as that of trolox. After incubation of platelets with antioxidants, the resveratrol intraplatelet concentration was about five times lower than the intracellular concentration of trolox. Although both antioxidants comparably lowered hydroxyl radical and malondialdehyde production in platelets stimulated with collagen, TxB(2) levels were decreased by resveratrol much more effectively than by trolox. Cyclooxygenase 1 was inhibited by resveratrol and not by trolox. Our data indicate that antioxidants, apart from nonspecific redox or radical-quenching mechanisms, inhibit platelet activation also by specific interaction with target proteins. The results also show the importance of studying platelet activation under conditions of real blood flow in contact with reactive surfaces, e.g., using dynamic adhesion experiments.
- 000
- 03589naa a2200541 a 4500
- 001
- bmc12008603
- 003
- CZ-PrNML
- 005
- 20200930102610.0
- 008
- 120316s2009 xxu eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $d ABA008
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hlaváčková, Alžběta $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 00 Prague 2, Czech Republic. $7 xx0122087
- 245 10
- $a Antioxidants change platelet responses to various stimulating events / $c A Sobotkova, L Masova-Chrastinova, J Suttnar, J Stikarova, P Majek, Z Reicheltova, R Kotlin, JW Weisel, M Maly, JE Dyr
- 520 9_
- $a The role of platelets in hemostasis may be influenced by alteration of the platelet redox state-the presence of antioxidants and the formation of reactive oxygen and nitrogen species. We investigated the effects of two antioxidants, resveratrol and trolox, on platelet activation. Trolox and resveratrol inhibited aggregation of washed platelets and platelet-rich plasma activated by ADP, collagen, and thrombin receptor-activating peptide. Resveratrol was a more effective agent in reducing platelet static and dynamic adhesion in comparison with trolox. The antioxidant capacity of resveratrol was, however, the same as that of trolox. After incubation of platelets with antioxidants, the resveratrol intraplatelet concentration was about five times lower than the intracellular concentration of trolox. Although both antioxidants comparably lowered hydroxyl radical and malondialdehyde production in platelets stimulated with collagen, TxB(2) levels were decreased by resveratrol much more effectively than by trolox. Cyclooxygenase 1 was inhibited by resveratrol and not by trolox. Our data indicate that antioxidants, apart from nonspecific redox or radical-quenching mechanisms, inhibit platelet activation also by specific interaction with target proteins. The results also show the importance of studying platelet activation under conditions of real blood flow in contact with reactive surfaces, e.g., using dynamic adhesion experiments.
- 536 __
- $c Grant Number: NS10633-3 (United States NINDS NIH HHS)
- 536 __
- $c Grant Number: R01 HL030954-24 (United States NHLBI NIH HHS)
- 536 __
- $c Grant Number: R01 HL090774-03 (United States NHLBI NIH HHS)
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a antioxidancia $x farmakologie $7 D000975
- 650 02
- $a trombocyty $x fyziologie $x účinky léků $7 D001792
- 650 02
- $a buněčná adheze $x fyziologie $x účinky léků $7 D002448
- 650 02
- $a kultivované buňky $7 D002478
- 650 02
- $a chromany (dihydrobenzopyrany) $x farmakologie $7 D002839
- 650 02
- $a kolagen $7 D003094
- 650 02
- $a cyklooxygenasa 1 $x metabolismus $7 D051545
- 650 02
- $a hemostáza $x účinky léků $7 D006487
- 650 02
- $a lidé $7 D006801
- 650 02
- $a malondialdehyd $x metabolismus $7 D008315
- 650 02
- $a agregace trombocytů $x fyziologie $x účinky léků $7 D010974
- 650 02
- $a stilbeny $x farmakologie $7 D013267
- 650 02
- $a thromboxan B2 $x metabolismus $7 D013929
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Chrastinová, Leona $7 xx0122084
- 700 1_
- $a Suttnar, Jiří, $d 1949- $7 xx0061396
- 700 1_
- $a Stikarova, Jana
- 700 1_
- $a Májek, Pavel $7 xx0128730
- 700 1_
- $a Riedelová, Zuzana $7 xx0126185
- 700 1_
- $a Kotlin, Roman
- 700 1_
- $a Weisel John W.
- 700 1_
- $a Malý, Martin, $d 1966- $7 mzk2004241073
- 700 1_
- $a Dyr, Jan E.
- 773 0_
- $t Free Radical Biology & Medicine $p Free Radic Biol Med $g Roč. 47, č. 12 (2009), s. 1707-1714 $w MED00001857 $x 1210-0668
- 773 0_
- $p Free Radic Biol Med $g 47(12):1707-14, 2009 Dec 15
- 910 __
- $a ABA008 $b x $y 4 $z 0
- 990 __
- $a 20120319124543 $b ABA008
- 991 __
- $a 20200930102607 $b ABA008
- 999 __
- $a ok $b bmc $g 901954 $s 765498
- BAS __
- $a 3
- BMC __
- $a 2009 $b 47 $c 12 $d 1707-1714 $m Free radical biology & medicine $x MED00001857
- GRA __
- $a NS10633 $p MZ0
- LZP __
- $a 2012-1Q10/jj